What's new

RSS
Date Content
31/08/2018 News and press releases: Development of medicines for rare diseases (updated)
31/08/2018 Human medicines European public assessment report (EPAR): pixantrone dimaleate, Pixuvri, pixantrone dimaleate, Lymphoma, Non-Hodgkin, 10/05/2012, 18, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): bevacizumab, Avastin, bevacizumab, Carcinoma, Non-Small-Cell Lung, Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Carcinoma, Renal Cell, 12/01/2005, 50, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): mycophenolate mofetil, CellCept, mycophenolate mofetil, Graft Rejection, 14/02/1996, 30, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): oseltamivir, Tamiflu, oseltamivir, Influenza, Human, 20/06/2002, 33, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): empagliflozin / linagliptin, Glyxambi, empagliflozin / linagliptin, Diabetes Mellitus, Type 2, 11/11/2016, 4, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): colistimethate sodium, Colobreathe, colistimethate sodium, Cystic Fibrosis, 13/02/2012, 9, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): lutropin alfa, Luveris, lutropin alfa, Ovulation Induction, Infertility, Female, 29/11/2000, 19, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): mercaptamine bitartrate, Cystagon, mercaptamine bitartrate, Cystinosis, 23/06/1997, 14, Authorised (updated)
31/08/2018 Human medicines European public assessment report (EPAR): pemetrexed, Ciambra, pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma, 02/12/2015, 2, Authorised (updated)